Compare Revvity Inc (RVTY) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Tenet Healthcare Corporation — how do they compare? Revvity Inc trades at $116.5 (market cap $12.91B), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and Revvity Inc pays a 0.24% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| RVTY | THC | |
|---|---|---|
Market Cap | $12.91B | $20.89B |
Sector | Technology | Health |
52-Week High | $117.75 | $262.63 |
52-Week Low | $82.26 | $161.37 |
Enterprise Value | $15.23B | $31.97B |
Dividend Yield | 0.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
